ロード中...
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
The sulfonylureas stimulate insulin release from pancreatic β cells, and have been a cornerstone of Type 2 diabetes pharmacotherapy for over 50 years. Although sulfonylureas are effective antihyperglycemic agents, interindividual variability exists in drug response (i.e., pharmacodynamics), disposit...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2860269/ https://ncbi.nlm.nih.gov/pubmed/20222815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erc.09.154 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|